nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Unspecified disorder of autonomic nervous system—Cyclosporine—focal segmental glomerulosclerosis	0.0722	0.0722	CcSEcCtD
Salbutamol—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.061	0.061	CcSEcCtD
Salbutamol—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.0326	0.0326	CcSEcCtD
Salbutamol—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0257	0.0257	CcSEcCtD
Salbutamol—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.0235	0.0235	CcSEcCtD
Salbutamol—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0178	CcSEcCtD
Salbutamol—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0176	0.0176	CcSEcCtD
Salbutamol—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0176	0.0176	CcSEcCtD
Salbutamol—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.017	0.017	CcSEcCtD
Salbutamol—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0159	CcSEcCtD
Salbutamol—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0153	CcSEcCtD
Salbutamol—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0152	CcSEcCtD
Salbutamol—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.015	CcSEcCtD
Salbutamol—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.015	CcSEcCtD
Salbutamol—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0136	CcSEcCtD
Salbutamol—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0134	CcSEcCtD
Salbutamol—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0127	0.0127	CcSEcCtD
Salbutamol—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.012	CcSEcCtD
Salbutamol—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0118	CcSEcCtD
Salbutamol—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0116	CcSEcCtD
Salbutamol—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Salbutamol—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0112	CcSEcCtD
Salbutamol—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0109	CcSEcCtD
Salbutamol—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0107	CcSEcCtD
Salbutamol—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0103	CcSEcCtD
Salbutamol—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00989	0.00989	CcSEcCtD
Salbutamol—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00989	0.00989	CcSEcCtD
Salbutamol—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00952	0.00952	CcSEcCtD
Salbutamol—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00918	0.00918	CcSEcCtD
Salbutamol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00905	0.00905	CcSEcCtD
Salbutamol—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00875	0.00875	CcSEcCtD
Salbutamol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00854	0.00854	CcSEcCtD
Salbutamol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00846	0.00846	CcSEcCtD
Salbutamol—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00835	0.00835	CcSEcCtD
Salbutamol—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00812	0.00812	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00807	0.00807	CcSEcCtD
Salbutamol—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00784	0.00784	CcSEcCtD
Salbutamol—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00759	0.00759	CcSEcCtD
Salbutamol—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00755	0.00755	CcSEcCtD
Salbutamol—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00755	0.00755	CcSEcCtD
Salbutamol—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00753	0.00753	CcSEcCtD
Salbutamol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00753	0.00753	CcSEcCtD
Salbutamol—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00739	0.00739	CcSEcCtD
Salbutamol—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00731	0.00731	CcSEcCtD
Salbutamol—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00727	0.00727	CcSEcCtD
Salbutamol—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.00699	CcSEcCtD
Salbutamol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00697	0.00697	CcSEcCtD
Salbutamol—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.00695	CcSEcCtD
Salbutamol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00692	0.00692	CcSEcCtD
Salbutamol—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0069	CcSEcCtD
Salbutamol—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00687	0.00687	CcSEcCtD
Salbutamol—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.00683	CcSEcCtD
Salbutamol—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.00682	CcSEcCtD
Salbutamol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00648	0.00648	CcSEcCtD
Salbutamol—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00645	0.00645	CcSEcCtD
Salbutamol—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.00631	CcSEcCtD
Salbutamol—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00627	CcSEcCtD
Salbutamol—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00624	0.00624	CcSEcCtD
Salbutamol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00621	0.00621	CcSEcCtD
Salbutamol—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00609	0.00609	CcSEcCtD
Salbutamol—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00605	0.00605	CcSEcCtD
Salbutamol—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.00596	CcSEcCtD
Salbutamol—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00594	0.00594	CcSEcCtD
Salbutamol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Salbutamol—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00588	CcSEcCtD
Salbutamol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.00582	CcSEcCtD
Salbutamol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00567	0.00567	CcSEcCtD
Salbutamol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00562	0.00562	CcSEcCtD
Salbutamol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00556	CcSEcCtD
Salbutamol—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.00553	CcSEcCtD
Salbutamol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00546	0.00546	CcSEcCtD
Salbutamol—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00544	CcSEcCtD
Salbutamol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00528	0.00528	CcSEcCtD
Salbutamol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.00523	CcSEcCtD
Salbutamol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Salbutamol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Salbutamol—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00515	CcSEcCtD
Salbutamol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00514	CcSEcCtD
Salbutamol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00509	CcSEcCtD
Salbutamol—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00504	CcSEcCtD
Salbutamol—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00494	CcSEcCtD
Salbutamol—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00494	0.00494	CcSEcCtD
Salbutamol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00491	0.00491	CcSEcCtD
Salbutamol—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00484	0.00484	CcSEcCtD
Salbutamol—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.0048	CcSEcCtD
Salbutamol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00478	CcSEcCtD
Salbutamol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00471	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0045	0.0045	CcSEcCtD
Salbutamol—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00447	0.00447	CcSEcCtD
Salbutamol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.00444	CcSEcCtD
Salbutamol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0044	CcSEcCtD
Salbutamol—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00439	CcSEcCtD
Salbutamol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00435	0.00435	CcSEcCtD
Salbutamol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00429	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00426	CcSEcCtD
Salbutamol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00426	CcSEcCtD
Salbutamol—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00422	CcSEcCtD
Salbutamol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00422	CcSEcCtD
Salbutamol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00407	CcSEcCtD
Salbutamol—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00404	0.00404	CcSEcCtD
Salbutamol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00392	CcSEcCtD
Salbutamol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00391	CcSEcCtD
Salbutamol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00391	CcSEcCtD
Salbutamol—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00364	CcSEcCtD
Salbutamol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.00354	CcSEcCtD
Salbutamol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00349	CcSEcCtD
Salbutamol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.00338	CcSEcCtD
Salbutamol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00327	0.00327	CcSEcCtD
Salbutamol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00314	0.00314	CcSEcCtD
Salbutamol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00311	CcSEcCtD
Salbutamol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.00311	CcSEcCtD
Salbutamol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00309	0.00309	CcSEcCtD
Salbutamol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.00293	CcSEcCtD
